Media Resources


Analogue Insulin on WHO Model List of Essential Medicines

MEPs can deliver strong message to Commission on TRIPS waiver

WHO Members States must not miss opportunity to improve lives of over 460 million people with diabetes

Nearly 400 MEPs and MPs Join Chorus of Voices Calling for a TRIPS Waiver on COVID-19 Vaccines

HAI Statement on the Oslo Medicines Initiative


Health Action International Statement on the European Commission Pharmaceutical Strategy

HAI Statement to the 73rd WHA on public health, innovation and IP

HAI Statement to the WHO Executive Board – COVID-19

HAI Statement on Improving Access to Insulin

HAI Statement to the 70th Session of the WHO Regional Committee for Europe

COVID-19: Future of Pharmaceuticals Webinar

Medical Technologies for COVID-19 Developed with Public Money Must be Recognised as Global Public Goods

HAI during COVID-19

Statement on the Results of EP Plenary on COVID-19 Response

Guarantee transparency, affordability and availability of EU funded therapies for COVID-19, demand MEPs

CJEU ruling is victory that resonates for all in favour of greater transparency


Expert Panel Discusses Concern on Use of Publicly Funded Knowledge in Medicines Development

EU Lawmakers Raise Alarm at Lack of Commitment to Enforcing Clinical Trial Data Transparency

Les législateurs de l’UE sonnent l’alarme sur le manque d’engagement à faire respecter la transparence des données des essais cliniques

Half of Cancer Drug Approvals Rely on Results of Potentially Biased Clinical Trials

Health Action International Comments on WHO Decision on Long-acting Analogue Insulin

Breaking Down Barriers to Accessing Internationally Controlled Essential Medicines Key to Ending Pain and Suffering of Millions

Snakebite Incidents, Response, & Antivenom Supply (Uganda)

Snakebite Incidents, Response, & Antivenom Supply (Kilifi County, Kenya)

HAI Snakebite Project in Sub-Saharan Africa

Policy Brief- WHA 72- The need for Global Action to Reduce Snakebite Death and Disability

Statement to WHA72 on Access to Medicines and Vaccines

Statement to WHA72 on the Global Challenge of Antimicrobial Resistance

HAI Welcomes European Parliament Backing of SPC Manufacturing Waiver

Governments who Support Transparency Must Raise Their Voices at the World Health Assembly